*Cardinal Health INC (CAH) Stake Held by Nelson Van Denburg & Campbell Wealth Management Group Llc

Cardinal Health, Inc. (NYSE:CAH) Corporate LogoBig Money Sentiment decreased to 0.96 in 2018 Q2. It has change of 0.04, from 2018Q1’s 1. The ratio dropped due to CAH positioning: 65 sold and 200 reduced. 65 funds acquired positions and 190 increased positions. Investors holded 279.84 million in 2018Q1 but now own 265.24 million shares or 5.22% less. Hexavest has 934,216 shs for 0.59% of their capital. Citigroup, New York-based fund reported 83,399 shs. Hikari Tsushin holds 0.05% or 4,018 shs. Asset Mgmt One Ltd owns 503,780 shs or 0.05% of their US capital. Everence Capital Mgmt, a Indiana-based fund reported 8,170 shs. Campbell And Co Adviser Ltd Liability Co reported 0.38% in Cardinal Health, Inc. (NYSE:CAH). Cornerstone Advsr invested 0.01% in Cardinal Health, Inc. (NYSE:CAH). Stevens Capital Mngmt Ltd Partnership owns 12,255 shs. 4.46 million are owned by Amer Century Companies Inc. Loring Wolcott & Coolidge Fiduciary Advisors Llp Ma holds 0% or 530 shs. Minnesota-based Riverbridge Prtn Ltd Liability has invested 0.02% in Cardinal Health, Inc. (NYSE:CAH). 150 are held by Guinness Asset Mngmt Limited. Rockland Tru accumulated 15,599 shs. 1832 Asset Mgmt Ltd Partnership reported 355 shs stake. 10,005 were reported by Cypress Cap Gru.

CAH registered $194,798 net activity with 0 insider purchases and 2 selling transactions since August 20, 2018. LAWS STUART G had sold 804 shs worth $44,662 on Monday, November 12.

Nelson Van Denburg & Campbell Wealth Management Group Llc’s stake in Cardinal Health Inc (CAH) is reduced by 95.36% based on its latest 2018Q2 regulatory filing with the SEC. 7,005 shares were sold by Nelson Van Denburg & Campbell Wealth Management Group Llc as the company’s stock declined 2.32% while stock markets rallied. At the end of 2018Q2, the institutional investor held 341 shares of the health care company, priced at $358,000, down from 7,346 at the end of the previous reported quarter. For a total of shares it increased its holding in by shares in the quarter, and has risen its stake in .

Earnings report for Cardinal Health, Inc. (NYSE:CAH) is awaited on February, 14., according to Zacks. Last year’s EPS was $1.31, while now analysts expect change of 16.03 % down from current $1.10 EPS. CAH’s profit could reach $327.74 million if the current EPS of $1.10 is accurate. Last quarter $1.29 EPS was reported. Analysts forecasts -14.73 % negative EPS growth this quarter.

Another two news for Cardinal Health, Inc. (NYSE:CAH) were briefly posted by: Businesswire.com on December 06, 2018 with title “Taubman Announces Two New Independent Directors, Two Director Retirements and New Committee Appointments – Business Wire”. The other Benzinga.com‘s article was titled “9 Policy Catalysts For Health Care Investors To Watch Before Year’s End – Benzinga” and posted on November 25, 2018.

Cardinal Health, Inc. (NYSE:CAH) Ratings Coverage

Total analysts of 4 have positions in Cardinal Health (NYSE:CAH) as follows: 1 rated it a “Buy”, 1 with “Sell” and 2 with “Hold”. The positive are 25%. Since July 3, 2018 according to StockzIntelligence Inc Cardinal Health has 5 analyst reports. On Tuesday, July 3 the rating was maintained by Morgan Stanley with “Underweight”. On Friday, November 16 the firm earned “Market Perform” rating by Leerink Swann. On Monday, July 16 the stock of Cardinal Health, Inc. (NYSE:CAH) has “Buy” rating given by Argus Research. On Monday, December 3 the stock of Cardinal Health, Inc. (NYSE:CAH) earned “Underweight” rating by Morgan Stanley. On Tuesday, August 7 the rating was maintained by Robert W. Baird with “Neutral”.

Cardinal Health, Inc. (NYSE:CAH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.